Press Releases
The latest press releases from A4LI can be found below.
Press Releases
- Support for Healthy Lifespan Extension Remains Stable, But More Education on the Field is NeededSupport for Healthy Lifespan Extension Remains Stable, But More Education on the Field is Needed May 3, 2022 – A new national poll of registered voters in the United States demonstrates broad support for scientific interventions that would increase healthy human lifespan. The poll, which was conducted by Public Policy Polling on behalf of The Alliance ...READ MORE
- The Alliance for Longevity Initiatives Announces Formation and Members of Scientific Advisory BoardThe Alliance for Longevity Initiatives Announces Formation and Members of Scientific Advisory Board March 2, 2022 – The Alliance for Longevity Initiatives (A4LI), a nonprofit organization advocating for social and political action around the issues of combating age-related chronic conditions and increasing healthy human lifespan, today announced the formation of a Scientific Advisory Board comprised of ...READ MORE
- A4LI Statement on the Appointment of Dr. Francis Collins as Science Advisor to the PresidentA4LI Statement on the Appointment of Dr. Francis Collins as Science Advisor to the President February 23, 2022 – The Alliance for Longevity Initiatives (A4LI) applauds the Biden administration’s appointment of Dr. Francis Collins as Science Advisor to the President and urges the administration to make the appointment permanent. Read the full press release.READ MORE
- The Alliance for Longevity Initiatives Announces Appointment of Paul Cherukuri, Ph.D. to Board of DirectorsThe Alliance for Longevity Initiatives Announces Appointment of Paul Cherukuri, Ph.D. to Board of Directors February 11, 2022 – The Alliance for Longevity Initiatives (A4LI) today announced the appointment of. Paul Cherukuri to the A4LI Board of Directors. Dr. Cherukuri joined as the tenth member of the Board in November 2021. Read the full press release.READ MORE
- New Poll Demonstrates Bipartisan Support for Therapies that Target Aging and Associated ResearchNew Poll Demonstrates Bipartisan Support for Therapies that Target Aging and Associated Research January 20, 2022 – A new national poll of registered voters in the United States shows that the majority of respondents would utilize pharmaceutical intervention to target aspects of aging if the drugs or therapies were safe, effective, affordable, and available to all. ...READ MORE